gy8ctl vs. gy0ctl | | | |
hsa03030: DNA replication | 28 | 5.85E-19 | POLA1, POLA2, RPA3, RPA1, PRIM1, RPA2, POLE4, MCM7, POLE3, FEN1 |
hsa04110: Cell cycle | 43 | 1.91E-11 | E2F1, E2F2, DBF4, PRKDC, PKMYT1, CHEK1, CDC45, MCM7, CDKN2B, CDKN2C … |
hsa03430: Mismatch repair | 16 | 1.15E-09 | EXO1, SSBP1, MSH2, LIG1, MLH1, RPA3, RFC5, POLD3, RPA1, RPA2 … |
hsa00240: Pyrimidine metabolism | 32 | 2.00E-08 | POLR2G, DTYMK, POLA1, CAD, POLA2, CMPK2, TK1, PRIM1, TYMS, POLE4 … |
hsa03410: Base excision repair | 16 | 2.06E-06 | HMGB1, UNG, NEIL3, LIG1, POLE, NEIL1, POLD3, POLD4, POLE4, POLE3 … |
hsa03440: Homologous recombination | 14 | 3.36E-06 | RAD51C, XRCC3, NBN, BLM, SSBP1, MRE11A, EME1, RPA3, RAD51, POLD3 … |
hsa03420: Nucleotide excision repair | 15 | 2.25E-04 | LIG1, POLE, RPA3, RFC5, POLD3, RPA1, RPA2, POLD4, RFC3, POLE4 … |
hsa00230: Purine metabolism | 33 | 3.73E-04 | XDH, POLR2G, POLA1, POLA2, PFAS, PRIM1, POLE4, POLE3, PDE4A, ENTPD8 … |
hsa05200: Pathways in cancer | 52 | 0.010417112 | FGF19, E2F1, HSP90AB1, E2F2, PTGS2, PDGFB, PGF, STAT5A, ARNT2, FGF11 … |
hsa05219: Bladder cancer | 11 | 0.016627297 | E2F1, E2F2, TYMP, CDKN1A, PGF, VEGFA, RB1, DAPK2, CDK4, MMP2, DAPK1 |
hsa04115: p53 signaling pathway | 15 | 0.018499656 | CDK1, CYCS, CHEK1, ATR, CDK4, CCNG2, GTSE1, CCNB1, CDKN1A, CCNB2 … |
hsa04512: ECM-receptor interaction | 17 | 0.024887625 | HSPG2, SDC4, COL5A1, CHAD, HMMR, VWF, LAMB3, LAMB2, ITGB8, ITGA5 … |
hsa03020: RNA polymerase | 8 | 0.03298698 | POLR3G, POLR2G, POLR3K, POLR1E, POLR1A, POLR1C, POLR1B, POLR3B |
hsa00970: Aminoacyl-tRNA biosynthesis | 10 | 0.036943456 | IARS, NARS2, LARS, FARSB, EPRS, WARS2, DARS2, AARS2, KARS, EARS2 |
hsa03040: Spliceosome | 22 | 0.044130211 | NCBP1, MAGOH, TRA2B, LSM6, TRA2A, SNRPD1, HSPA1A, PRPF4, RBMX, HNRNPA1 … |
hsa05222: Small cell lung cancer | 16 | 0.048720159 | E2F1, TRAF1, E2F2, CKS1B, PTGS2, PIK3CD, CYCS, SKP2, RB1, BIRC3 … |
gy8rita vs. gy8ctl | | | |
hsa03410: Base excision repair | 4 | 0.014381142 | NEIL1, LIG3, PARP3, SMUG1 |
hsa05212: Pancreatic cancer | 5 | 0.021107952 | AKT1, PGF, PIK3CB, ERBB2, RALGDS |
hsa05213: Endometrial cancer | 4 | 0.040674333 | AKT1, PIK3CB, ERBB2, CTNNA1 |
hsa04150: mTOR signaling pathway | 4 | 0.040674333 | AKT1, PGF, PIK3CB, EIF4E2 |